$0.16
-0.07 (-30.20%)
Open$0.23
Previous Close$0.24
Day High$0.23
Day Low$0.14
52W High$13.28
52W Low$0.14
Volume—
Avg Volume1.34M
Market Cap829.7K
P/E Ratio—
EPS$-0.88
SectorBiotechnology
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 78.0K | 6.85M | 7.13M |
| Net Income | -5,336,521 | -1,263,411 | -1,351,255 |
| Profit Margin | -6,852.2% | -18.4% | -19.0% |
| EBITDA | -5,993,013 | -2,085,898 | -2,131,542 |
| Free Cash Flow | — | -871,023 | -1,277,993 |
| Rev Growth | — | +20.2% | +21.4% |
| Debt/Equity | 0.02 | 0.33 | 0.37 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $294.45 | -0.18% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $467.06 | -0.22% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $167.95 | -1.05% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $542.62 | -0.81% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $951.19 | -0.86% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.65 | -2.00% | 7.7 | 20.98B |